3QNW

Caspase-6 in complex with Z-VAD-FMK inhibitor

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 0.287 
  • R-Value Work: 0.240 
  • R-Value Observed: 0.243 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history. 


Literature

Structure of human caspase-6 in complex with Z-VAD-FMK: New peptide binding mode observed for the non-canonical caspase conformation.

Muller, I., Lamers, M.B., Ritchie, A.J., Dominguez, C., Munoz-Sanjuan, I., Kiselyov, A.

(2011) Bioorg Med Chem Lett 21: 5244-5247

  • DOI: 10.1016/j.bmcl.2011.07.041
  • Primary Citation of Related Structures:  
    3QNW

  • PubMed Abstract: 

    • Caspase-6 is a cysteine protease implicated in neuronal survival and apoptosis. Deregulation of caspase-6 activity was linked to several neurodegenerative disorders including Alzheimer's and Huntington's Diseases. Several recent studies on the structure of caspase-6 feature the caspase-6 zymogen, mature apo-caspase-6 as well as the Ac-VEID-CHO peptide complex ...

    Caspase-6 is a cysteine protease implicated in neuronal survival and apoptosis. Deregulation of caspase-6 activity was linked to several neurodegenerative disorders including Alzheimer's and Huntington's Diseases. Several recent studies on the structure of caspase-6 feature the caspase-6 zymogen, mature apo-caspase-6 as well as the Ac-VEID-CHO peptide complex. All structures share the same typical dimeric caspase conformation. However, mature apo-caspase-6 crystallized at low pH revealed a novel, non-canonical inactive caspase conformation speculated to represent a latent state of the enzyme suitable for the design of allosteric inhibitors. In this treatise we present the structure of caspase-6 in the non-canonical inactive enzyme conformation bound to the irreversible inhibitor Z-VAD-FMK. The complex features a unique peptide binding mode not observed previously.

    Organizational Affiliation: 

    BioFocus, Chesterford Research Park, Saffron Walden, Essex, CB10 1XL, UK.



Macromolecules
Find similar proteins by: 
(by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Caspase-6 A, C, E, G156Homo sapiensMutation(s): 0 
Gene Names: CASP6, MCH2
EC: 3.4.22.59
Find proteins for P55212 (Homo sapiens)
Explore P55212 
Go to UniProtKB:  P55212
NIH Common Fund Data Resources
PHAROS:  P55212
GTEx:  ENSG00000138794
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by: 
(by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Caspase-6 B, D, F, H100Homo sapiensMutation(s): 0 
Gene Names: CASP6, MCH2
EC: 3.4.22.59
Find proteins for P55212 (Homo sapiens)
Explore P55212 
Go to UniProtKB:  P55212
NIH Common Fund Data Resources
PHAROS:  P55212
GTEx:  ENSG00000138794
Protein Feature View
Expand
  • Reference Sequence
  • Find similar proteins by:  Sequence   |   Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
Z-VAD-FMK X, Y, Z5synthetic constructMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Biologically Interesting Molecules (External Reference) 1 Unique
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 0.287 
  • R-Value Work: 0.240 
  • R-Value Observed: 0.243 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 87.206α = 90
b = 65.446β = 91.24
c = 91.718γ = 90
Software Package:
Software NamePurpose
GDAdata collection
PHASERphasing
REFMACrefinement
XDSdata reduction
SCALAdata scaling

Structure Validation

View Full Validation Report


View more in-depth experimental data

Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2011-09-21
    Type: Initial release
  • Version 1.1: 2013-02-27
    Changes: Other